Literature DB >> 6228949

The heart disease of Friedreich's ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases.

A E Harding, R L Hewer.   

Abstract

One hundred and fifteen patients with carefully defined Friedreich's ataxia were assessed clinically and electrocardiographically for evidence of heart disease. Cardiac symptoms, of which dyspnoea and palpitations were the most frequent, occurred in less than 30 per cent. Abnormalities on clinical examination were present in a similar proportion; harsh systolic murmurs, ventricular hypertrophy and added heart sounds were the commonest of these. Cardiac failure and persistent arrhythmias were rare and occurred late in the evolution of the neurological disease. Two patients presented with heart disease before developing neurological symptoms. Cardiac signs and symptoms were uncommon in patients without electrocardiographic abnormalities. About two-thirds of the cases had definitely abnormal ECG recordings. The characteristic finding was of widespread T-wave inversion with ventricular hypertrophy. Serial ECGs, recorded over periods of up to 32 years, were available in 30 cases and showed that abnormalities may develop in patients with Friedreich's ataxia at any time up until 20 years after the onset of neurological symptoms. In four patients initial ECG abnormalities had either improved or disappeared subsequently.

Entities:  

Mesh:

Year:  1983        PMID: 6228949

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  33 in total

1.  Autonomic function in Friedreich's ataxia.

Authors:  T J Ingall; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

Review 2.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

3.  Friedreich's ataxia presenting after cardiac transplantation.

Authors:  H Leonard; R Forsyth
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

4.  Oligomerization propensity and flexibility of yeast frataxin studied by X-ray crystallography and small-angle X-ray scattering.

Authors:  Christopher A G Söderberg; Alexander V Shkumatov; Sreekanth Rajan; Oleksandr Gakh; Dmitri I Svergun; Grazia Isaya; Salam Al-Karadaghi
Journal:  J Mol Biol       Date:  2011-10-25       Impact factor: 5.469

5.  Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia.

Authors:  T N James; B W Cobbs; H C Coghlan; W C McCoy; C Fisch
Journal:  Br Heart J       Date:  1987-05

6.  Development of Wolff-Parkinson-White syndrome in a patient with Friedreich's ataxia.

Authors:  R N Baldwin; R J Lane
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

7.  Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia.

Authors:  Matthias L Jauslin; Silvia Vertuani; Elisa Durini; Lisa Buzzoni; Nunzia Ciliberti; Sara Verdecchia; Paola Palozza; Thomas Meier; Stefano Manfredini
Journal:  Mol Cell Biochem       Date:  2007-05-03       Impact factor: 3.396

8.  Friedreich's ataxia presenting with pure sensory ataxia: a long-term follow-up study of two patients.

Authors:  J Berciano; O Combarros; J Calleja; J M Polo; J Pascual; C Leno
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

9.  A family segregating a Friedreich ataxia phenotype that is not linked to the FRDA locus.

Authors:  P Smeyers; E Monrós; J Vílchez; J Lopez-Arlandis; F Prieto; F Palau
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

10.  Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.

Authors:  Yuxi Shan; Robert A Schoenfeld; Genki Hayashi; Eleonora Napoli; Tasuku Akiyama; Mirela Iodi Carstens; Earl E Carstens; Mark A Pook; Gino A Cortopassi
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.